US Patent Issued to Mitotherapeutix, University of Vermont and State Agricultural College on Oct. 27 for "Compositions and methods for inhibiting expression of methylation-controlled J-protein (MCJ)" (Colorado, New Jersey Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,464, issued on Oct. 27, was assigned to Mitotherapeutix LLC (Cheshire, Conn.) and University of Vermont and State Agricultural College (Burlington, Vt.).

"Compositions and methods for inhibiting expression of methylation-controlled J-protein (MCJ)" was invented by Pengcheng Patrick Shao (Fanwood, N.J.) and Mercedes Rincon (Aurora, Colo.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions and methods useful to reduce expression of methylation-controlled J-protein (MCJ) gene and for treatment of MCJ-associated diseases and conditions are provided. Provided are MCJ dsRNA agents, MCJ antisense polynucleotide agents, compositions comprising MCJ d...